Advertise
NEWSLETTER
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
3D Bio-printing

All the way from regenerative research to commercialisation

Professor Jean Hérbert's new book Replacing Aging argues that regenerative medicine is the key to Longevity.

Is Longevity actually just Replacing Aging?

A year in Longevity: different perspectives

Looking for anti-aging solutions in some unusual places. 2020 has seen Longevity.Technology covering a variety of

Scientists in China have created a micro robot which they say could enable 3D in vivo bioprinting inside the body.

Micro robots could print tissue inside the body

Researchers believe they may have made a major breakthrough with a 3D printed blood vessel which reports on its health automatically.

3D printed blood vessel can monitor its own health

Bio-printed implants optimised with growth factors show promise in the repair of bone defects, tissue regeneration and vascularisation.

The X-factor required for bio-printed growth success

Zoltan Istvan announces candidacy for US President, with aging society a key concern

Exclusive: Interview with US presidential candidate

Researchers 3D bio-print a working heart pump with real human cells

3D lattice structure of a tissue implanted directly onto a soft living tissue. Credit: Ohio State University

The inside track on 3D-bioprinting

Axolotl’s Biosciences lead product, called ThinkInk, is a novel versatile bio-ink for bioprinting stem cell-derived neural tissues.

New 3D bio-ink start-up targets neural tissue

Longevity Technology Trinity College Dublin

Bioengineering breakthrough for patching broken hearts

Body on a Chip OOC

“Human-on-a-Chip” OOC to revolutionise preclinical

Vancouver-based Aspect Biosystems is world’s most well-funded 3D bioprinting company. We spoke to the company’s founder and CEO, Tamer Mohamed

Aspect Biosystems talks regeneration

Aspects Biosystems

Aspect Biosystems raises $20m for human bioprinting

Mini livers can be printed within 90 days

Mini livers can be printed within 90 days

Longevity Technology Aline Miller Manchester Biogels

Supporting research and organ growth. Literally

A strategic partnership between CELLINK and Made in Space promises advances for drug screening and cancer treatments.

Final frontier – 3D bioprinting in space

Miguel Oliveira from Universidade do Minho

University of Minho to spin out bioprinting start-up

After a unique 3D bio-printing research symposium in London we chat with UCL's expert: Dr Deepak Kalaskar 

Interview: 3D bioprinting realties and timescales

Hydrogel that is responsive to light is set to push boundaries in the 3D bioprinting market.

Hydrogels set sights on biomedical applications

3D bioprinting breakthrough in vascular systems

3D bioprinting breakthrough in vascular systems

Harvard researchers develop new 3D printing technique for vascularisation

Breakthrough in 3D printing vascular channels

A first-mover in lab-printed tissues has halted its lead-program and cut back on staff. What does this mean for the bioprinting market?

Has bioprinting hit a jam?

Carnegie Mellon develops ground-breaking technique to fast track bio-printing human organs.

Major breakthrough in bio-printing organs

European Space Agency advances tissue replacement by using 3D-bioprinting in space.

One small step for 3D-bioprinting, one giant leap for Longevity

3D bio-printing is the newest trend which aims to fill the lack of available organs for transplants say researchers in San Diego.

3D-printed vascular system breakthrough

Breakthrough in bio-printing gives tissue engineers a breath of fresh air

Breakthrough in bio-printing gives tissue engineers a breath of fresh air

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed